Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $89.5000 (2.64%) ($86.9200 - $89.7900) on Fri. Jan. 18, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.26% (three month average) | RSI | 48 | Latest Price | $89.5000(2.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.5% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(59%) VYM(50%) DIA(49%) IVE(48%) SPLV(48%) | Factors Impacting ABBV price | ABBV will decline at least -1.13% in a week (0% probabilities). TLT(-14%) VXX(-12%) UUP(-12%) VIXM(-11%) XHB(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.13% (StdDev 2.26%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
5 Day Moving Average | $86.5(3.47%) | 10 Day Moving Average | $87.23(2.6%) | 20 Day Moving Average | $87.18(2.66%) | To recent high | -3.9% | To recent low | 16.4% | Market Cap | $157.903b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |